Slide from Katherine Tuttles presentation, during FLOW session, 61st European Renal Association Congress Conclusion The FLOW trial showed that semaglutide significantly decreased the risk of progression of kidney disease in T2DM, without significant increases in serious adverse events
Nevertheless, some pharmacological evidence suggests discontinuing the use of Semaglutide once pregnancy is confirmed to steer away from any possibility of fetal suffering
If your nausea is severe, lasts all week, or prevents you from eating and drinking, you should consult your healthcare provider to discuss a potential dosage adjustment
The "Ozempic Face" and Rapid-Loss Phenotype Rapid weight loss, whether from GLP-1 therapy, very-low-calorie diets, or bariatric surgery, can produce similar visible changes: reduced facial adipose tissue, changes in skin laxity, and altered body contour
Neuron 85(6):11931199
Always treat these substances as research chemicals and maintain a peptide database to track batch numbers and personal physiological responses over time